You just read:

DSPE Regulatory Update: Acceptance of the European Medicines Agency Submission for an Atypical Antipsychotic Agent Lurasidone

News provided by

Dainippon Sumitomo Pharma Europe Ltd

25 Oct, 2012, 07:00 BST